1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Renata PLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia. Eltrombopag 25 MG, Prednisolone - Primary Immune Thrombocytopenia | Phase 1 / Phase 2 | Recruiting | Renata PLC | 100 | 2025-02-07 | 2025-02-18 |
Purpura, Thrombocytopenic, Idiopathic (1)
Prednisolone (1) · eltrombopag (1)
Bangladesh (1)
Md Manirul Islam, MBBS,FCPS (1)
PMID 19846889, PMID 24802773, PMID 29270980, PMID 30344993, PMID 34452956